Clinical Trials Logo

Clinical Trial Summary

This randomized, single blind study will compare the antiviral effect of Pegasys (pegylated interferon alfa-2a) plus placebo versus Pegasys plus tenofovir in patients with chronic hepatitis D. Patients will be randomized to receive 96 weeks of therapy with Pegasys (180 micrograms sc weekly) plus either placebo (orally daily) or tenofovir (245mg orally daily). Anticipated time on study treatment is 2+ years, target sample size is <50.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01088659
Study type Interventional
Source Hoffmann-La Roche
Contact
Status Completed
Phase Phase 3
Start date February 16, 2010
Completion date December 29, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05461170 - SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection. Phase 2
Active, not recruiting NCT04535544 - A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus Phase 2
Completed NCT02732639 - A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD) Phase 3
Completed NCT02731131 - A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD) Phase 2
Completed NCT02765802 - A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection Phase 2
Active, not recruiting NCT05229991 - Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection Phase 3
Terminated NCT01861444 - An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a) N/A
Active, not recruiting NCT03105310 - Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D Phase 2
Recruiting NCT04166266 - Observatory of Efficacy and Safety of Bulevirtide in Patients With Chronic HBV/HDV Co-infection
Completed NCT00686790 - Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603) Phase 3
Completed NCT02876419 - A Long Term Follow-up Study of Patients From the REP 301 Protocol